Due Diligence Preparation
Whether you are looking to license your product or enter into a joint venture development agreement, your target partner company will perform an extensive due diligence investigation before investing in your company. The goal of your potential partner's due diligence team is to place a probability on not only the chances of your product's success, but also on the amount of revenue the partner can realize from partnering with your company. You will be asked to produce internal documents and data that will allow the due diligence team to determine if your technology will fit into the partner's current portfolio of therapies. TDA will help you position your company for success during this process and increase your chances of closing a favorable deal with your target partner.
Target Analysis
Targeting the right healthcare company can make or break your product's prospects and your company's survival. TDA will help you screen potential partners for portfolio prominence and fit, therapeutic alignment, market position, and strategic direction.
Data Room
TDA can host your data room and help you compile the documents needed for the due diligence process including previous regulatory body correspondence, preclinical and clinical studies, internal and external publications, IND applications/dossiers and CMC plans.
Business Case
During negotiations with your target partner, financial and marketing models for your product will be deconstructed. We will help you defend your product against currently approved interventions, the pipelines of competitors, and payer reimbursement and VBC risk analyses.
Before you enter into the due diligence process with a target partner, you will want to have a detailed reimbursement strategy in place for your product. The feasibility and clarity of this strategy will give your target partner confidence that the financial projections for your product's reimbursement is achievable and that they will realize a return on their investment. TDA can help you prepare for negotiations by analyzing the current market access environment for your product, modeling current payer reimbursement for you target indication, and conducting comparative effectiveness research into the additional benefits of your intervention over the current standard of care. We have access to large data sets that include 100s of millions of patient encounters represented by EHRs and medical claims and which can be used for rigorous, observational pharmaco-economic studies into the efficacy of your product's intervention.